Literature DB >> 11120887

A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.

W Resch1, N Parkin, E L Stuelke, T Watkins, R Swanstrom.   

Abstract

Rapidly evolving entities, such as viruses, can undergo complex genetic changes in the face of strong selective pressure. We have developed a modified heteroduplex tracking assay (HTA) capable of detecting the presence of single, specific mutations or sets of linked mutations. The initial application of this approach, termed multiple-site-specific (MSS) HTA, was directed toward the detection of mutations in the HIV-1 pro gene at positions 46, 48, 54, 82, 84, and 90, which are associated with resistance to multiple protease inhibitors. We demonstrate that MSS HTA is sensitive and largely specific to all targeted mutations. The assay allows the accurate and reproducible quantitation of viral subpopulations comprising 3% or more of the total population. Furthermore, we used MSS HTA in longitudinal studies of pro gene evolution in vitro and in vivo. In the examples shown here, populations turned over rapidly and more than one population was present frequently. To demonstrate the versatility of MSS HTA, we also constructed a probe sensitive to changes at positions 181 and 184 of the RT coding domain. Changes at these positions are involved in resistance to nevirapine and 2',3'-dideoxy-3'-thiacytidine (3TC), respectively. This assay easily detected the evolution of resistance to 3TC. MSS HTA provides a rapid and sensitive approach for detecting the presence of and quantifying complex mixtures of distinct genotypes, including genetically linked mutations, and, as one example, represents a useful tool for following the evolution of drug resistance during failure of HIV-1 antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120887      PMCID: PMC14564          DOI: 10.1073/pnas.98.1.176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Complete mutagenesis of the HIV-1 protease.

Authors:  D D Loeb; R Swanstrom; L Everitt; M Manchester; S E Stamper; C A Hutchison
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

2.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  R W Shafer; D R Jung; B J Betts; Y Xi; M J Gonzales
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 3.  Efficient site-directed mutagenesis using uracil-containing DNA.

Authors:  T A Kunkel; K Bebenek; J McClary
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Complete nucleotide sequences of functional clones of the AIDS virus.

Authors:  L Ratner; A Fisher; L L Jagodzinski; H Mitsuya; R S Liou; R C Gallo; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

5.  Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing.

Authors:  B A Larder; A Kohli; P Kellam; S D Kemp; M Kronick; R D Henfrey
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

6.  Rapid classification of phenylketonuria genotypes by analysis of heteroduplexes generated by PCR-amplifiable synthetic DNA.

Authors:  N Wood; L Tyfield; J Bidwell
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

7.  Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.

Authors:  E L Delwart; H W Sheppard; B D Walker; J Goudsmit; J I Mullins
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

Authors:  L H Ping; J A Nelson; I F Hoffman; J Schock; S L Lamers; M Goodman; P Vernazza; P Kazembe; M Maida; D Zimba; M M Goodenow; J J Eron; S A Fiscus; M S Cohen; R Swanstrom
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.

Authors:  Q Gao; Z Gu; M A Parniak; J Cameron; N Cammack; C Boucher; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

10.  Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

Authors:  D D Richman; D Havlir; J Corbeil; D Looney; C Ignacio; S A Spector; J Sullivan; S Cheeseman; K Barringer; D Pauletti
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more
  29 in total

1.  Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.

Authors:  Magdalena Magierowska; Flavien Bernardin; Seema Garg; Silvija Staprans; Michael D Miller; Koen K A Van Rompay; Eric L Delwart
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 2.  Minority variants of drug-resistant HIV.

Authors:  Sara Gianella; Douglas D Richman
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

3.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

4.  Independent evolution of human immunodeficiency virus type 1 env V1/V2 and V4/V5 hypervariable regions during chronic infection.

Authors:  Patrick R Harrington; Julie A E Nelson; Kathryn M Kitrinos; Ronald Swanstrom
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Multiplex mutagenically separated polymerase chain reaction assay for rapid detection of human mitochondrial DNA variations in coding area.

Authors:  Jin Wu; Peng Ran; Beilei Zhang; Yingbi Li; Jing Yan; Miao Liao; Yiping Hou; Lin Zhang
Journal:  Croat Med J       Date:  2008-02       Impact factor: 1.351

6.  Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor.

Authors:  Kerry Gordon; Shatha Omar; Andile Nofemela; Gama Bandawe; Carolyn Williamson; Zenda Woodman
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-20       Impact factor: 2.205

7.  Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly.

Authors:  Wolfgang Resch; Rainer Ziermann; Neil Parkin; Andrea Gamarnik; Ronald Swanstrom
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay.

Authors:  Diane Sitki-Green; Rachel H Edwards; Jennifer Webster-Cyriaque; Nancy Raab-Traub
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.

Authors:  William L Ince; Patrick R Harrington; Gretja L Schnell; Milloni Patel-Chhabra; Christina L Burch; Prema Menezes; Richard W Price; Joseph J Eron; Ronald I Swanstrom
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.